Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies.

Blanco-Pérez F, Papp G, Goretzki A, Möller T, Anzaghe M, Schülke S.

Arch Immunol Ther Exp (Warsz). 2019 Jun 20. doi: 10.1007/s00005-019-00551-8. [Epub ahead of print] Review.

PMID:
31222414
2.

NFκB- and MAP-Kinase Signaling Contribute to the Activation of Murine Myeloid Dendritic Cells by a Flagellin A:Allergen Fusion Protein.

Moeller T, Wolfheimer S, Goretzki A, Scheurer S, Schülke S.

Cells. 2019 Apr 15;8(4). pii: E355. doi: 10.3390/cells8040355.

3.

The vaccine adjuvant MPLA activates glycolytic metabolism in mouse mDC by a JNK-dependent activation of mTOR-signaling.

Blanco-Pérez F, Goretzki A, Wolfheimer S, Schülke S.

Mol Immunol. 2019 Feb;106:159-169. doi: 10.1016/j.molimm.2018.12.029. Epub 2019 Jan 9.

PMID:
30623816

Supplemental Content

Loading ...
Support Center